History of Zollinger–Ellison syndrome

Zollinger–Ellison syndrome, characterized by the triad of peptic ulceration, gastric acid hypersecretion, and pancreatic tumors, remained entirely unrecognized as a distinct clinical entity until the mid-twentieth century, despite the fact that severe and recurrent peptic ulcer disease had been observed and puzzled over by physicians for generations. Before its formal description, patients whose conditions would later be understood as manifestations of this syndrome were treated within the prevailing frameworks for ordinary peptic ulcer disease, often with confounding and ultimately fatal outcomes. The syndrome's identification represented a convergence of surgical observation, physiological research, and growing understanding of the endocrine functions of the gastrointestinal tract.

Historical Narrative

Peptic ulcer disease in its various forms had been recognized since antiquity, with ancient physicians describing abdominal pain, wasting, and hemorrhage in terms that historians have retrospectively interpreted as consistent with ulceration of the stomach and intestines. Galen attributed gastric ailments to corruption of the humors and excess of bile, a framework that governed European medical thinking on digestive disorders for many centuries. Medieval physicians working within both the Islamic and Christian scholarly traditions elaborated on these humoral explanations without fundamentally challenging them.

The nineteenth century transformed understanding of peptic ulcer disease more profoundly than any prior era. Jean Cruveilhier, the French pathologist, contributed early systematic anatomical descriptions of gastric ulcers in the 1830s, establishing them as a recognized pathological entity distinct from cancer and other gastric lesions. Subsequent decades saw growing recognition that ulcers could affect the duodenum as well as the stomach, and by the late nineteenth century, surgeons in Europe and North America had begun operating on patients with severe ulcer disease, developing procedures to reduce gastric acid production or bypass damaged sections of the gastrointestinal tract.

The physiological revolution in gastroenterology came with Ivan Pavlov's work on the nervous regulation of digestion, recognized by the Nobel Prize in 1904, and with the discovery of secretin by William Bayliss and Ernest Starling in 1902, which introduced the concept of hormonal regulation of digestive function. Starling himself coined the word 'hormone' in 1905. These discoveries established that the gastrointestinal tract was not merely a passive conduit but an active endocrine organ, a conceptual foundation without which Zollinger–Ellison syndrome could not have been understood.

The syndrome's formal identification came in 1955, when Robert M. Zollinger and Edwin H. Ellison, surgeons at Ohio State University, published a paper describing two patients with unusually severe, recurrent, and refractory peptic ulceration associated with non-insulin-secreting tumors of the pancreatic islet cells and markedly elevated gastric acid secretion. Zollinger and Ellison proposed that the tumors were producing a humoral substance that stimulated the stomach to secrete acid in pathological quantities, a hypothesis that was bold at the time because it implicated the pancreas in the regulation of gastric function in a way not previously established.

The substance hypothesized by Zollinger and Ellison was eventually identified as gastrin, a hormone previously described in more limited contexts. Roderic Gregory and Hilda Tracy at the University of Liverpool isolated and characterized gastrin in the early 1960s, and investigators subsequently demonstrated that the pancreatic tumors in Zollinger–Ellison syndrome, which came to be called gastrinomas, produced gastrin in massive excess. This identification linked the syndrome definitively to a specific biochemical mechanism and validated the foundational hypothesis of the 1955 paper, closing the loop on a discovery that had begun with two perplexing surgical cases and ended by illuminating an entirely new dimension of gastrointestinal endocrinology.

Key Historical Figures

• Robert M. Zollinger
• Edwin H. Ellison
• Jean Cruveilhier
• Ivan Pavlov
• William Bayliss
• Ernest Starling
• Roderic Gregory
• Hilda Tracy

Historical narrative only — this page describes how Zollinger–Ellison syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.